Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025)
Eton Pharmaceuticals' (ETON) quarterly FCF Margin came in at 54.51% in Q4 2025, down 4784.0% year-on-year from 1.16% in Q4 2024, and down 204.26% quarter-over-quarter from 52.28% in Q3 2025.
Eton Pharmaceuticals (ETON) FCF Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals has disclosed FCF Margin across 7 years of filings, most recently posting 54.51% for Q4 2025.
- FCF Margin for Q4 2025 came in at 54.51%, down 4784.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 15.81% (up 1339.0% YoY), and the FY2025 annual result was 12.75%, up 1033.0% from the prior year.
- FCF Margin came in at 54.51% for Q4 2025 at Eton Pharmaceuticals, down from 52.28% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 117.02% in Q1 2025 to a low of 380.9% in Q3 2021.
- The 5-year median for FCF Margin is 13.13% (2024), against an average of 7.79%.
- Peak annual rise in FCF Margin reached 1425297 bps in 2021, while the deepest fall reached 24095071 bps in 2021.
- Eton Pharmaceuticals' FCF Margin stood at 84.05% in 2021, then soared by 140 bps to 33.28% in 2022, then slumped by 96 bps to 1.3% in 2023, then sank by 614 bps to 6.67% in 2024, then slumped by 717 bps to 54.51% in 2025.
- The last three FCF Margin figures came in at 54.51% (Q4 2025), 52.28% (Q3 2025), and 42.05% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -5.22% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 12.86% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 46.39% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 16.78% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -2.77% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -429.96% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 32.62% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 13.24% |
| 10 | Eton Pharmaceuticals | 806.97 Mn | 781.03 Mn | 13.10 Mn | -54.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -54.51% |
| Sep 30, 2025 | 52.28% |
| Jun 30, 2025 | 42.05% |
| Mar 31, 2025 | 117.02% |
| Dec 31, 2024 | -6.67% |
| Sep 30, 2024 | 28.59% |
| Jun 30, 2024 | 13.83% |
| Mar 31, 2024 | -31.22% |
| Dec 31, 2023 | 1.30% |
| Sep 30, 2023 | 12.42% |
| Jun 30, 2023 | 59.21% |
| Mar 31, 2023 | -29.19% |
| Dec 31, 2022 | 33.28% |
| Sep 30, 2022 | -52.90% |
| Jun 30, 2022 | 49.00% |
| Mar 31, 2022 | 55.51% |
| Dec 31, 2021 | -84.05% |
| Sep 30, 2021 | -380.90% |
| Jun 30, 2021 | -12.03% |
| Mar 31, 2021 | 31.23% |